JP2023502415A5 - - Google Patents
Info
- Publication number
- JP2023502415A5 JP2023502415A5 JP2022529304A JP2022529304A JP2023502415A5 JP 2023502415 A5 JP2023502415 A5 JP 2023502415A5 JP 2022529304 A JP2022529304 A JP 2022529304A JP 2022529304 A JP2022529304 A JP 2022529304A JP 2023502415 A5 JP2023502415 A5 JP 2023502415A5
- Authority
- JP
- Japan
- Prior art keywords
- infection
- pharmaceutical composition
- pharmaceutically acceptable
- group
- compound according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1916915.0 | 2019-11-20 | ||
| GBGB1916915.0A GB201916915D0 (en) | 2019-11-20 | 2019-11-20 | Compounds |
| PCT/GB2020/052961 WO2021099793A1 (en) | 2019-11-20 | 2020-11-19 | 1-aminosulfonyl-2-carboxypyrrole derivatives as metallo-beta-lactamase inhibitors |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023502415A JP2023502415A (ja) | 2023-01-24 |
| JP2023502415A5 true JP2023502415A5 (https=) | 2023-11-27 |
| JP7642635B2 JP7642635B2 (ja) | 2025-03-10 |
Family
ID=69063150
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022529304A Active JP7642635B2 (ja) | 2019-11-20 | 2020-11-19 | メタロ－ベータ－ラクタマーゼ阻害剤としての１－アミノスルホニル－２－カルボキシピロール誘導体 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US12544359B2 (https=) |
| EP (1) | EP4061800A1 (https=) |
| JP (1) | JP7642635B2 (https=) |
| KR (1) | KR102940573B1 (https=) |
| CN (2) | CN114728902B (https=) |
| AU (1) | AU2020385668A1 (https=) |
| BR (1) | BR112022008938A2 (https=) |
| CA (1) | CA3156194A1 (https=) |
| GB (1) | GB201916915D0 (https=) |
| IL (1) | IL293015A (https=) |
| MX (1) | MX2022006109A (https=) |
| WO (1) | WO2021099793A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102807772B1 (ko) * | 2018-05-16 | 2025-05-14 | 인펙스 테라퓨틱스 리미티드 | 항균 화합물 |
| GB201916915D0 (en) | 2019-11-20 | 2020-01-01 | Amr Centre Ltd | Compounds |
| GB202015885D0 (en) * | 2020-10-07 | 2020-11-18 | Infex Therapeutics Ltd | Synthesis of pyrrole acid derivatives |
| CN117050063B (zh) * | 2023-08-14 | 2024-02-09 | 宁夏佰斯特医药化工有限公司 | 一种三氟乙酸酯三氮唑衍生物的合成方法 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2003216312A1 (en) | 2002-02-19 | 2003-09-09 | Northwestern University | NON-COVALENT INHIBITORS OF AmpC ss-LACTAMASE |
| GB201310542D0 (en) | 2013-06-13 | 2013-07-31 | Antabio Sas | Compounds |
| EP3096754B1 (en) | 2014-01-22 | 2018-08-29 | Merck Sharp & Dohme Corp. | Metallo-beta-lactamase inhibitors |
| GB201521059D0 (en) * | 2015-11-30 | 2016-01-13 | Isis Innovation | Inhibitors of metallo-beta-lactamases |
| CN112165936B (zh) | 2018-05-14 | 2023-11-28 | 国立大学法人东海国立大学机构 | β-内酰胺酶抑制剂 |
| KR102807772B1 (ko) * | 2018-05-16 | 2025-05-14 | 인펙스 테라퓨틱스 리미티드 | 항균 화합물 |
| GB2578093B (en) | 2018-10-09 | 2020-11-18 | Verona Pharma Plc | Liquid pharmaceutical composition comprising RPL554 and HFA-134A |
| GB201916915D0 (en) | 2019-11-20 | 2020-01-01 | Amr Centre Ltd | Compounds |
| GB202015885D0 (en) * | 2020-10-07 | 2020-11-18 | Infex Therapeutics Ltd | Synthesis of pyrrole acid derivatives |
-
2019
- 2019-11-20 GB GBGB1916915.0A patent/GB201916915D0/en not_active Ceased
-
2020
- 2020-11-19 JP JP2022529304A patent/JP7642635B2/ja active Active
- 2020-11-19 EP EP20812414.9A patent/EP4061800A1/en active Pending
- 2020-11-19 IL IL293015A patent/IL293015A/en unknown
- 2020-11-19 CA CA3156194A patent/CA3156194A1/en active Pending
- 2020-11-19 BR BR112022008938A patent/BR112022008938A2/pt unknown
- 2020-11-19 CN CN202080080912.8A patent/CN114728902B/zh active Active
- 2020-11-19 KR KR1020227019182A patent/KR102940573B1/ko active Active
- 2020-11-19 US US17/778,261 patent/US12544359B2/en active Active
- 2020-11-19 AU AU2020385668A patent/AU2020385668A1/en active Pending
- 2020-11-19 WO PCT/GB2020/052961 patent/WO2021099793A1/en not_active Ceased
- 2020-11-19 CN CN202411235522.XA patent/CN119100967A/zh active Pending
- 2020-11-19 MX MX2022006109A patent/MX2022006109A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023502415A5 (https=) | ||
| IL278571B2 (en) | Antibacterial compounds | |
| JP2021524866A5 (https=) | ||
| Buckley et al. | Imipenem/cilastatin: a reappraisal of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy | |
| CN107108624B (zh) | 用于治疗耐药性细菌感染的组合疗法 | |
| HRP20130928T1 (hr) | C7-fluor supstituirani spojevi tetraciklina | |
| US8557979B2 (en) | Carbapenem antibacterials with gram-negative activity and processes for their preparation | |
| ES2653837T3 (es) | Antibacterianos carbapenem con actividad gramo-negativa | |
| CN110312715A (zh) | 用于抗生素耐药性细菌菌株感染的使用脒取代的β-内酰胺化合物和β-内酰胺酶抑制剂的组合疗法 | |
| JP2014521631A (ja) | スルバクタム及びベータ−ラクタマーゼインヒビターを含む医薬組成物 | |
| KR20160108400A (ko) | 7-옥소-1,6-디아자바이사이클로[3.2.1]옥탄 유도체 및 이의 항박테리아제로서의 용도 | |
| Kanj et al. | In vitro activity of tigecycline and comparators against Gram-positive and Gram-negative isolates collected from the Middle East and Africa between 2004 and 2011 | |
| AU2020297184A1 (en) | Biofilm disruption | |
| CN106414444B (zh) | 含氮化合物以及它们的用途 | |
| DK2734203T3 (en) | A pharmaceutical composition for the treatment of a respiratory disease | |
| KR102694317B1 (ko) | 세균 감염의 치료를 위한 카바페넴 화합물 및 조성물 | |
| JP5276653B2 (ja) | カルバペネム類を含む殺菌性抗ｍｒｓａ活性医薬組成物 | |
| KR20170032480A (ko) | 항균제 및 타조박탐을 포함하는 조성물 | |
| KR20160126004A (ko) | 항세균제를 포함하는 제약학적 조성물 | |
| JP2015524461A (ja) | 環状骨格ペプチドとの組合せ | |
| JP2025519511A (ja) | 一酸化窒素放出化合物を含む多成分医薬組成物及びキット、並びにその使用方法 | |
| CN106163519A (zh) | 包含抗菌剂的药物组合物 | |
| CN106102741A (zh) | 包含抗菌剂的药物组合物 | |
| JP2002525275A (ja) | カルバペネム抗菌組成物および治療方法 | |
| US20150065416A1 (en) | Novel drug combination |